Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C

Hepatology. 2000 Nov;32(5):1089-95. doi: 10.1053/jhep.2000.19287.

Abstract

As a part of the defense mechanism of the host to viral infection, interferons induce the transcription of several genes. These interferon-inducible genes contribute to the eradication of the viruses. Whereas some studies suggested the participation of a dsRNA-dependent protein kinase in the host reaction to hepatitis C virus infection, the involvement of other interferon-inducible genes has not been evaluated. Furthermore, there has been no analysis on the expression profile of multiple interferon-inducible genes. The aim of this study was to clarify the hepatic mRNA expression profile of interferon-inducible genes with a special concern to chronic hepatitis C. A total of 76 liver biopsy samples (28 with chronic hepatitis C, 10 with chronic hepatitis B, 9 with alcoholic liver disease, 14 with autoimmune hepatitis, 10 with primary biliary cirrhosis, and 5 of normal liver) were enrolled. The expression of the following genes was quantified by competitive reverse transcription-polymerase chain reaction and was compared according to the etiology; dsRNA-dependent protein kinase (PKR), 2',5'-oligoadenylate synthetase (2,5-AS), latent cellular endoribonuclease (RNase L), RNase L inhibitor, and MxA. As a result, PKR mRNA was significantly overexpressed in the liver of chronic hepatitis C compared with those of other etiologies (P =.0178), and it correlated significantly with serum alanine transaminase values (r =.51, P =.0054). Also, the expression of the RNase L inhibitor showed a significant reduction in chronic hepatitis C (P =.0184). The expressions of 2,5-AS, RNase L, and MxA were not different significantly irrespective to the etiology. In conclusion, hepatic overexpression of PKR and reduced expression of RNase L inhibitor seem to contribute to the anti-HCV mechanism characteristically.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters*
  • Adult
  • Aged
  • Antiviral Agents / therapeutic use*
  • Chaperonins*
  • Female
  • Gene Expression Regulation / drug effects
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / genetics
  • Hepatitis C, Chronic / metabolism
  • Humans
  • Interferons / therapeutic use*
  • Liver / metabolism*
  • Liver Diseases / drug therapy*
  • Liver Diseases / genetics*
  • Male
  • Middle Aged
  • Protein Kinases / metabolism
  • Proteins / genetics
  • RNA, Double-Stranded / physiology
  • RNA, Messenger / metabolism*
  • Suppression, Genetic
  • Virus Diseases / prevention & control*
  • eIF-2 Kinase / genetics

Substances

  • ABCE1 protein, human
  • ATP-Binding Cassette Transporters
  • Antiviral Agents
  • Proteins
  • RNA, Double-Stranded
  • RNA, Messenger
  • Interferons
  • Protein Kinases
  • eIF-2 Kinase
  • Chaperonins